Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2025-12-24 @ 1:16 PM
NCT ID:
NCT02024295
Brief Summary:
To determine the efficacy and safety S-adenosyl-l-methionine in alcoholic hepatitis with cholestasis.
Detailed Description:
randomize first time for core treatment stage for 6 weeks, then randomized second time for extend treatment for 42 weeks.
Study:
NCT02024295
Study Brief:
Protocol Section:
NCT02024295